Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.

These short- to mid-term safety, oncological and QoL outcome data endorse results from smaller series and show the ability of salvage focal IRE to safely achieve oncological control in patients with radio-recurrent PCa.